MilliporeSigma will launch its ADC Express™ services, which provide rapid production of ADCs for best candidate selection.
October 1, 2019
WHO: Antibody drug conjugate (ADC) experts from MilliporeSigma. The Life Science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada.
WHAT: MilliporeSigma will launch its ADC Express™ services, which provide rapid production of ADCs for best candidate selection. ADC Express™ Services use established platform technology to reliably scale target molecules while reducing time to clinic. This new service gives access to ADCs without the need to invest in potent handling capabilities. Members of the media are invited to learn more about ADC Express™ services by speaking with MilliporeSigma’s experts at World ADC San Diego 2019.
WHEN: Thursday, October 10, 2019 through Friday, October 11, 2019 at booth #23.
WHERE: Manchester Grand Hyatt, 1 Market Pl., San Diego, California 92101.
WHY: MilliporeSigma’s comprehensive ADC service portfolio combines the following drug development and production steps: mAb solutions, linker, payload and final conjugation — all from a single source.
Media representatives are encouraged to visit MilliporeSigma booth #23 to learn more about MilliporeSigma’s ADC Express™ Services and speak with subject matter experts.
Follow MilliporeSigma on Twitter @MilliporeSigma, on Facebook @MilliporeSigma and on LinkedIn.
All Merck KGaA, Darmstadt, Germany news releases are distributed by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About the Life Science Business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has some 21,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Udit Batra is the global chief executive officer of MilliporeSigma.
Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $125 billion global life science industry.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 51,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck KGaA, Darmstadt, Germany generated sales of €14.8 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck, KGaA, Darmstadt, Germany, visit www.emdgroup.com.
